This will be the second conference of its kind for the organisation. The first, held in December
2016, covered an overview of the e-cigarette market and regulatory responsibility in the e-cigarette
value chain.
This year, the varied agenda includes:
• Current and emerging regulations for e-cigarettes, including USA FDA Deeming Regulations and
European Commission Tobacco Products Directive.
• Legal standards and compliance concerns.
• Testing standards and submission processes and protocols and
• Other regulatory perspectives, including USA states, Canada, and the rest of the world.
ENDS US will be held on December 6-7, 2017 in the Embassy Suites by the Hilton in Alexandria
Oldtown, Alexandria Virginia.
* Meanwhile the FDA is to launch a new public health education campaign aimed at discouraging the
use of e-cigarettes and other electronic nicotine delivery systems by children.
It will expand its “The Real Cost” public education campaign to include messaging to teens about
the dangers of using these products this autumn while developing a full-scale campaign to launch in
2018.
“We will continue to work vigorously to keep all tobacco products out of the hands of kids,” said FDA
Commissioner Scott Gottlieb.
“Educating youth about the dangers of tobacco products has been a cornerstone of our efforts to
reduce the harms caused by these products. Including e-cigarettes and other ENDS products in our
prevention work makes sense.”
The FDA said it aims to strike a careful balance between the regulation of all tobacco products,
and the opportunity to encourage development of innovative tobacco products that may be less
dangerous than combustible cigarettes.
It said that in doing so it would also focus on the need to reduce the access and appeal of all tobacco
products to youth, including e-cigarettes and other ENDS.
Since August 2016, the FDA has issued over 6,400 warning letters to brick and mortar and online
retailers for selling newly-regulated tobacco products such as e-cigarettes to minors.
Mitch Zeller, J.D., director of the FDA’s Center for Tobacco Products said: “As we continue to learn
more about these products and their relationship to youth, the agency will be better prepared to help
address the issue of youth use through science-based educational efforts and regulatory policies that
will ultimately pay the greatest dividends in reducing tobacco-related disease and death.”
VM13 | 29